- Home
- PRTA vs WLKP Comparison
PRTA vs WLKP Comparison
Compare PRTA & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- WLKP
- Stock Information
- Founded
- PRTA 2012
- WLKP 2014
- Country
- PRTA Ireland
- WLKP United States
- Employees
- PRTA N/A
- WLKP N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- WLKP Major Chemicals
- Sector
- PRTA Health Care
- WLKP Industrials
- Exchange
- PRTA Nasdaq
- WLKP Nasdaq
- Market Cap
- PRTA 802.8M
- WLKP 791.6M
- IPO Year
- PRTA N/A
- WLKP 2014
- Fundamental
- Price
- PRTA $13.41
- WLKP $23.40
- Analyst Decision
- PRTA Buy
- WLKP
- Analyst Count
- PRTA 7
- WLKP 0
- Target Price
- PRTA $57.67
- WLKP N/A
- AVG Volume (30 Days)
- PRTA 448.2K
- WLKP 38.7K
- Earning Date
- PRTA 11-12-2024
- WLKP 11-05-2024
- Dividend Yield
- PRTA N/A
- WLKP 8.00%
- EPS Growth
- PRTA N/A
- WLKP 8.66
- EPS
- PRTA N/A
- WLKP 1.75
- Revenue
- PRTA $133,350,000.00
- WLKP $1,143,109,000.00
- Revenue This Year
- PRTA $46.28
- WLKP N/A
- Revenue Next Year
- PRTA N/A
- WLKP $5.56
- P/E Ratio
- PRTA N/A
- WLKP $13.42
- Revenue Growth
- PRTA N/A
- WLKP N/A
- 52 Week Low
- PRTA $12.31
- WLKP $21.19
- 52 Week High
- PRTA $41.55
- WLKP $24.34
- Technical
- Relative Strength Index (RSI)
- PRTA 43.50
- WLKP 52.61
- Support Level
- PRTA $12.31
- WLKP $23.68
- Resistance Level
- PRTA $14.28
- WLKP $24.20
- Average True Range (ATR)
- PRTA 0.98
- WLKP 0.43
- MACD
- PRTA 0.00
- WLKP -0.07
- Stochastic Oscillator
- PRTA 33.73
- WLKP 20.20
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.